Open Access
Research Article

Table 2

Data obtained from genetic analyses of all the 44 samples of Leishmania (Viannia) braziliensis studied.

Sample code* Therapeutic outcome Origin (state) Shared bands Similarity Index Cluster
L. braziliensis reference 1, 7, 8, 9 0.93 II
1071 R Rio de Janeiro 1, 7, 9, 10, 13 0.80 I
983 R Rio de Janeiro 1, 5, 7, 10 1 I
986 R Rio de Janeiro 1, 5, 7, 10 1 I
891 R Rio de Janeiro 1, 5, 7, 9, 10 0.93 I
133 R Rio de Janeiro 5, 7, 9, 10 0.89 I
766 R Rio de Janeiro 1, 5, 6, 7, 9, 10 1 I
768 R Rio de Janeiro 1, 5, 6, 7, 9, 10 1 I
1107 R Rio de Janeiro 1, 7, 8, 10 0.93 II
811 R Rio de Janeiro 1, 7, 8, 9, 10 0.93 II
475 NR Rio de Janeiro 1, 7, 9 0.93 II
554 R Rio de Janeiro 1, 7 1 II
345 NR Rio de Janeiro 1, 7 1 II
952 NR Rio de Janeiro 1, 7 1 II
378 NR Rio de Janeiro 1, 7 1 II
1517 NR Rio de Janeiro 1, 7 1 II
489 NR Rio de Janeiro 1, 7 1 II
469 R Rio de Janeiro 1, 4, 7 0.93 II
622 R Goiás 1, 6, 7, 10 0.93 II
530 NR Rio de Janeiro 1, 7, 10 1 II
1611 NR Bahia 1, 7, 10 1 II
992 R Rio de Janeiro 1, 4, 7, 10 0.93 II
145 NR Rio de Janeiro 1, 4, 7, 9, 10 0.93 II
600 R Rio de Janeiro 1, 7, 11 1 II
789 R Rio de Janeiro 1, 7, 11 1 II
409 R Rio de Janeiro 1, 2, 7, 11 0.93 II
501 R Rio de Janeiro 1, 3, 7, 11 0.92 II
299 R Rio de Janeiro 1, 4, 7, 8, 11 0.93 II
317 R Rio de Janeiro 1, 4, 7, 11 0.93 II
426 NR Rio de Janeiro 1, 7, 9, 10, 11 0.93 II
328 NR Rio de Janeiro 1, 7, 10, 11 0.93 II
946 NR Rondônia 1, 5, 7, 12 0.76 II
420 R Minas Gerais 7, 10, 12, 14 0.93 III
1300 NR Amazonas 7, 10, 12 1 III
389 NR Maranhão 7, 10, 12 1 III
1453 R Bahia 7, 10 1 III
1450 R Bahia 7, 10 1 III
291 NR Rio de Janeiro 4, 7, 10, 12 0.89 III
812 R Amazonas 4, 7, 9, 12 0.93 III
211 NR Rio de Janeiro 4, 7, 9, 10, 12 0.93 III
1059 NR Rio de Janeiro 7, 9, 10, 12 0.91 III
222 NR Rio de Janeiro 4, 7, 10, 11 1 III
96 NR Rio de Janeiro 4, 7, 10, 11 1 III
310 NR Rio de Janeiro 4, 7, 14 0.76 III
1127 NR Rio de Janeiro 10, 13 0.72 III

* Code of the Leishmania isolates.

R = responder group, NR = non-responder group (responder or non-responder to one course of treatment with meglumine antimoniate 5 mg Sb5+/kg/day or 20 mg Sb5+/kg/day).

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.